Impact of Physical Activity and Natural Bioactive Compounds on Endothelial Dysfunction in Chronic Kidney Disease

Impact of Physical Activity and Natural Bioactive Compounds on Endothelial Dysfunction in Chronic Kidney Disease

Chronic kidney disease (CKD) represents a world-wide public health problem. Inflammation, endothelial dysfunction (ED) and vascular calcifications are clinical features of CKD patients that increase cardiovascular (CV) mortality. CKD-related CV disease pathogenic mechanisms are not only associated w...

Full description

Bibliographic Details
Main Authors:	Elisa Grazioli, Annalisa Romani, Giulia Marrone, Manuela Di Lauro, Claudia Cerulli, Silvia Urciuoli, Arianna Murri, Cristina Guerriero, Eliana Tranchita, Manfredi Tesauro, Attilio Parisi, Nicola Di Daniele, Annalisa Noce
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Life
Subjects:	cardiovascular disease chronic kidney disease endothelial dysfunction endothelium natural bioactive compounds asymmetrical dimethylarginine
Online Access:	https://www.mdpi.com/2075-1729/11/8/841

Similar Items

Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022
by: Michalina Jezierska, et al.
Published: (2022-10-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

ASYMMETRIC DIMETHYLARGININE, THE PROMOTER FACTOR OF CARDIOVASCULAR PATHOLOGIES
by: Anamaria Vîlcea, et al.
Published: (2019-09-01)

Effect of Online Home-Based Training on Functional Capacity and Strength in Two CKD Patients: A Case Study
by: Giulia Marrone, et al.
Published: (2022-03-01)

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis
by: Maurício Batista Paes Landim, et al.
Published: (2009-05-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Increased Circulating ADMA in Young Male Rats Caused Cognitive Deficits and Increased Intestinal and Hippocampal NLRP3 Inflammasome Expression and Microbiota Composition Alterations: Effects of Resveratrol
by: Mei-Hsin Hsu, et al.
Published: (2023-05-01)

Impaired Endothelial Function in Hereditary Angioedema During the Symptom-Free Period
by: Davide Firinu, et al.
Published: (2018-05-01)

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
by: Dimitrios Tsikas
Published: (2020-06-01)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
by: Emilie H. Zobel, et al.
Published: (2017-07-01)

The association between coronary atherosclerotic burden and asymmetric dimethylarginine, carotis intima media thickness and endothelial function
by: Fatma Can, et al.
Published: (2014-12-01)

The relationship of asymmetric dimethylarginine levels with uncontrolled arterial hypertension and hypertension disease stage
by: Aleksandr N. Stafeev, et al.
Published: (2023-11-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE
by: S. N. Tolstov, et al.
Published: (2017-05-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Comparison of two methods for dimethylarginines quantification
by: Vendula Sudová, et al.
Published: (2024-03-01)

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
by: Laura Dowsett, et al.
Published: (2020-09-01)

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2016-12-01)

Asymmetric and symmetric dimethylarginine in patients presenting with risk factors for coronary heart disease
by: Ilic Marina, et al.
Published: (2012-10-01)

Serum symmetric dimethylarginine in older dogs: Reference interval and comparison of a gold standard method with the ELISA
by: Sofie Marynissen, et al.
Published: (2024-03-01)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
by: Ibrahim Kocayigit, et al.
Published: (2020-03-01)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
by: Shiyun Wang, et al.
Published: (2022-12-01)

ADMA and C-reactive protein as mortality predictors in dialysis patients
by: Ignjatović Aleksandra, et al.
Published: (2013-06-01)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
by: Chien-Ning Hsu, et al.
Published: (2021-09-01)

Nitric Oxide Synthesis Metabolites—As Potential Markers in Chronic Kidney Disease in Children
by: Joanna Piechowicz, et al.
Published: (2022-08-01)

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
by: Alvares Thiago, et al.
Published: (2012-06-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

Nitric Oxide Metabolites and Asymmetric Dimethylarginine Concentrations in Breast Milk
by: Hakan Öztürk, et al.
Published: (2017-04-01)

Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide
by: Li Zhang, et al.
Published: (2020-07-01)

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients
by: Osama Tayeh, et al.
Published: (2011-06-01)

Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin
by: Avci Emre, et al.
Published: (2020-01-01)

Associations of Biopterins and ADMA with Vascular Function in Peripheral Microcirculation from Patients with Chronic Kidney Disease
by: Samsul Arefin, et al.
Published: (2023-03-01)

Renoprotective Effects of Melatonin in Young Spontaneously Hypertensive Rats with L-NAME
by: Ming-Chou Cheng, et al.
Published: (2014-06-01)

α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease ProgressionPlain-Language Summary
by: Jing Qian, et al.
Published: (2021-11-01)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
by: Burkhard Poeggeler, et al.
Published: (2021-08-01)

Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
by: Iwona Bednarz-Misa, et al.
Published: (2020-08-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

The effects of erythropoietin on bacterial translocation and inflammatory response in an experimental intestinal obstruction model in rats
by: Kapan Murat, et al.
Published: (2013-01-01)